Trimetrexate Glucuronate Inj Articles
US Biosciences halts lodenosine HIV trial after death of patient
15 October 1999
USB plans 2000 filing for NeuTrexin in CRC
26 May 1999
US Drug Majors See 2nd-Half Double-Digit Growth
29 July 1996
USB, Alza Extend Product Collaboration
3 June 1996
US Bioscience Signs Euro Marketing Deal
17 July 1995
Eli Lilly Canada; Hexalen and Ethyol
8 May 1995
New Chemical Entities Round-Up For 1994
6 February 1995
First Approval For Ethyol, But FDA Panel Says No
19 December 1994
1st Cytoprotectant Set For EU Approval
3 October 1994
ROUND-UP OF 1993'S NEW CHEMICAL ENTITIES
31 January 1994
FDA YEAR-END APPROVALS FOR 1993
10 January 1994
US BIOSCIENCE'S AIDS-RELATED DRUG APPROVED
10 January 1994
NEUTREXIN TREATMENT IND
21 June 1993
US BIO TO FILE NEW NDA FOR ETHYOL?
29 March 1993
Showing 1-14 of 14 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
